Index RUT
P/E 42.16
EPS (ttm) 0.41
Insider Own 22.70%
Shs Outstand 19.09M
Perf Week -1.30%
Market Cap 332.39M
Forward P/E 23.88
EPS next Y 0.73
Insider Trans -1.62%
Shs Float 14.74M
Perf Month -0.91%
Income 8.07M
PEG -
EPS next Q 0.15
Inst Own 60.42%
Short Float / Ratio 0.31% / 0.58
Perf Quarter 4.50%
Sales 439.13M
P/S 0.76
EPS this Y 1525.00%
Inst Trans -0.44%
Short Interest 0.05M
Perf Half Y 45.37%
Book/sh 7.69
P/B 2.27
EPS next Y 12.31%
ROA 3.48%
Target Price 21.50
Perf Year 95.84%
Cash/sh 3.99
P/C 4.37
EPS next 5Y -
ROE 5.67%
52W Range 7.93 - 19.20
Perf YTD 109.50%
Dividend -
P/FCF 14.40
EPS past 5Y 50.65%
ROI 5.10%
52W High -9.22%
Beta 0.82
Dividend % -
Quick Ratio 1.28
Sales past 5Y 4.52%
Gross Margin 70.00%
52W Low 119.80%
ATR 0.53
Employees 800
Current Ratio 2.19
Sales Q/Q 6.41%
Oper. Margin 3.92%
RSI (14) 50.68
Volatility 2.33% 3.10%
Optionable Yes
Debt/Eq 0.11
EPS Q/Q 3058.70%
Profit Margin 1.84%
Rel Volume 0.95
Prev Close 17.13
Shortable Yes
LT Debt/Eq 0.08
Earnings Nov 07 AMC
Payout -
Avg Volume 78.28K
Price 17.43
Recom 1.00
SMA20 -0.16%
SMA50 1.32%
SMA200 27.62%
Volume 74,699
Change 1.75%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-15-21 Initiated
DA Davidson
Buy
$22
Apr-09-15 Initiated
Imperial Capital
In-line
$15
Jun-02-14 Initiated
Singular Research
Buy
$20
Mar-08-13 Reiterated
Imperial Capital
In-line
$17 → $15
Nov-08-23 11:52AM
Nov-07-23 05:58PM
(Associated Press Finance)
04:05PM
Oct-24-23 04:05PM
Sep-20-23 04:05PM
05:32PM
Loading…
Aug-09-23 05:32PM
(Associated Press Finance)
04:05PM
Jul-26-23 04:05PM
Jul-03-23 09:57AM
Jun-16-23 02:20PM
Jun-15-23 08:30AM
Jun-02-23 01:35PM
May-22-23 12:00PM
May-17-23 07:07AM
May-09-23 05:25PM
04:05PM
Loading…
04:05PM
May-08-23 08:30AM
May-03-23 04:05PM
Apr-25-23 04:05PM
Mar-18-23 02:55AM
Mar-16-23 08:23AM
Mar-15-23 04:05PM
Mar-01-23 04:05PM
Feb-08-23 11:19AM
Jan-24-23 07:06AM
Jan-14-23 04:37PM
Jan-01-23 09:17AM
Dec-12-22 08:12AM
Dec-06-22 12:00PM
07:00AM
09:32AM
Loading…
Nov-22-22 09:32AM
Nov-21-22 12:09PM
Nov-08-22 06:49AM
Nov-03-22 04:05PM
Oct-20-22 08:00AM
Oct-07-22 08:00AM
Sep-09-22 07:10AM
Sep-06-22 05:00PM
Aug-17-22 06:43AM
Aug-10-22 07:00PM
Aug-09-22 04:05PM
Aug-08-22 09:00AM
Jul-26-22 04:05PM
Jul-25-22 08:53AM
Jul-20-22 09:00AM
Jul-05-22 08:20AM
Jun-15-22 08:49AM
May-10-22 07:00AM
May-06-22 10:30PM
May-05-22 04:11PM
May-04-22 10:05AM
Apr-28-22 11:39AM
Apr-21-22 04:05PM
Apr-12-22 10:00AM
Apr-05-22 09:06AM
Apr-01-22 08:53PM
Mar-31-22 10:06AM
Mar-22-22 09:50AM
Mar-10-22 06:53AM
Mar-08-22 04:05PM
Mar-03-22 04:05PM
01:23PM
Feb-22-22 04:05PM
Feb-16-22 11:00AM
Feb-15-22 12:39PM
Jan-26-22 11:00AM
Jan-18-22 11:30AM
Jan-06-22 09:34AM
Jan-04-22 09:00AM
09:00AM
Dec-14-21 12:09PM
12:06PM
Dec-07-21 04:30PM
Dec-06-21 01:00PM
Nov-23-21 04:05PM
Nov-22-21 05:46AM
Nov-05-21 12:00PM
Nov-04-21 04:05PM
Nov-01-21 01:02PM
Oct-21-21 08:00AM
Oct-07-21 09:00AM
Oct-06-21 11:06AM
Sep-27-21 09:00AM
Sep-06-21 11:32AM
Sep-01-21 10:00AM
Aug-31-21 09:00AM
Aug-30-21 04:05PM
Aug-06-21 07:29AM
05:01AM
Aug-05-21 04:05PM
Jul-28-21 08:00AM
Jul-07-21 02:07PM
05:54AM
Jun-07-21 06:47AM
Jun-03-21 08:00AM
Jun-02-21 08:30AM
May-26-21 06:30AM
May-25-21 08:30AM
May-10-21 08:08AM
May-07-21 06:01AM
Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. Its product lines include general health, immune, cardiovascular, digestive, personal care, and weight management. It operates through the following geographical segments: Asia, Europe, North America, and Latin America and Other. The company was founded by Eugene L. Hughes, Kristine F. Hughes, and Pauline Hughes-Francis in 1972 and is headquartered in Lehi, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Norman Daniel C EVP & President, Asia Nov 30 Sale 17.06 13,000 221,780 54,765 Dec 01 01:58 PM Norman Daniel C EVP & President, Asia Nov 29 Sale 17.59 2,000 35,180 67,765 Dec 01 01:58 PM Brower Nathan G EVP, General Counsel Nov 21 Sale 17.31 3,999 69,223 43,760 Nov 27 03:37 PM Yates Bryant J EVP & President, Europe Aug 29 Option Exercise 13.88 15,000 208,200 109,150 Aug 31 05:18 PM Yates Bryant J EVP & President, Europe Aug 29 Sale 16.77 15,000 251,550 94,150 Aug 31 05:18 PM Norman Daniel C EVP & President, Asia Aug 28 Option Exercise 13.88 12,036 167,060 81,801 Aug 29 01:48 PM Norman Daniel C EVP & President, Asia Aug 28 Sale 16.40 12,036 197,390 69,765 Aug 29 01:48 PM Norman Daniel C EVP & President, Asia Aug 25 Option Exercise 13.88 200 2,776 69,965 Aug 29 01:48 PM Norman Daniel C EVP & President, Asia Aug 25 Sale 16.50 200 3,300 69,765 Aug 29 01:48 PM Yates Bryant J EVP & President, Europe Jun 09 Sale 12.09 1,767 21,363 95,703 Jun 21 08:23 PM Yates Bryant J EVP & President, Europe Jun 08 Sale 12.00 2,630 31,560 97,470 Jun 21 08:23 PM Yates Bryant J EVP & President, Europe Jun 05 Sale 11.20 1,315 14,728 100,100 Jun 21 08:23 PM Norman Daniel C EVP & President, Asia Jun 02 Sale 11.14 622 6,929 75,366 Jun 21 08:08 AM Yates Bryant J EVP & President, Europe Jun 02 Sale 11.19 618 6,915 101,415 Jun 21 08:23 PM Yates Bryant J EVP & President, Europe Jun 01 Sale 11.28 1,638 18,477 102,033 Jun 21 08:23 PM Norman Daniel C EVP & President, Asia Jun 01 Sale 11.29 1,025 11,572 75,988 Jun 21 08:08 AM Norman Daniel C EVP & President, Asia May 25 Sale 11.19 9,683 108,353 77,013 Jun 21 08:08 AM Yates Bryant J EVP & President, Europe May 25 Sale 11.36 1,500 17,040 103,671 Jun 21 08:23 PM Norman Daniel C EVP & President, Asia May 24 Sale 11.12 1,623 18,048 86,696 Jun 21 08:08 AM Norman Daniel C EVP & President, Asia May 23 Sale 11.13 2,311 25,721 88,319 Jun 21 08:08 AM Norman Daniel C EVP & President, Asia May 22 Sale 11.12 206 2,291 90,630 Jun 21 08:08 AM Brower Nathan G EVP, General Counsel May 19 Sale 10.85 3,128 33,939 49,053 Jun 01 11:31 AM Brower Nathan G EVP, General Counsel May 18 Sale 11.01 8,268 91,031 52,181 Jun 01 11:31 AM Brower Nathan G EVP, General Counsel Dec 09 Sale 8.18 4,972 40,671 48,989 Dec 14 05:59 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite